Benzinga | Mar 10, 2021 06:47AM EST

Zynerba Pharmaceuticals Q4 EPS $(0.33) Misses $(0.32) Estimate

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.32) by 3.13 percent. This is a 28.26 percent increase over losses of $(0.46) per share from the same period last year.